FDA, Guided Therapeutics Unveil Plan for Rejected LuViva Cervical Scanner PMA

Guided Therapeutics made new progress on its once-rejected pre-market approval bid for the LuViva advanced cervical cancer scanning system, which the FDA knocked with a “not approvable” letter in January.
Mass Device